HLA-A, -B, -C and -DRB1 Association with Autism Spectrum Disorder Risk: A Sex-Related Analysis in Italian ASD Children and Their Siblings.

Fecha de publicación:

Autores de CIPF

Participantes ajenos a CIPF

  • Guerini FR
  • Bolognesi E
  • Mensi MM
  • Zanette M
  • Agliardi C
  • Zanzottera M
  • Chiappedi M
  • Annunziata S
  • Cavallini A
  • Clerici M

Grupos de Investigación

Abstract

Autism Spectrum disorders (ASD) are diagnosed more often in males than in females, by a ratio of about 3:1; this is likely to be due to a difference in risk burden between the sexes and/or to "compensatory skills" in females, that may delay the diagnosis of ASD. Identifying specific risk factors for ASD in females may be important in facilitating early diagnosis. We investigated whether HLA- class I: -A, -B, -C and class II -DRB1 alleles, which have been suggested to play a role in the development of ASD, can be considered as sex-related risk/protective markers towards the ASD. We performed HLA allele genotyping in 178 Italian children with ASD, 94 healthy siblings, and their parents. HLA allele distribution was compared between children with ASD, sex-matched healthy siblings, and a cohort of healthy controls (HC) enrolled in the Italian bone marrow donor registry. Allele transmission from parents to children with ASD and their siblings was also assessed. Our findings suggest that HLA-A*02 , B*38 , and C*12 alleles are more frequently carried by females with ASD compared to both HC and healthy female siblings, indicating these alleles as potential risk factors for ASD in females. Conversely, the HLA-A*03 allele was more commonly transmitted to healthy female siblings, suggesting it might have a protective effect. Additionally, the HLA-B*44 allele was found to be more prevalent in boys with ASD, indicating it is a potential risk factor for male patients. This is the first Italian study of sex-related HLA association with ASD. If confirmed, these results could facilitate early ASD diagnosis in female patients, allowing earlier interventions, which are crucial in the management of neurodevelopmental disorders.

Datos de la publicación

ISSN/ISSNe:
1422-0067, 1422-0067

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES  MDPI

Tipo:
Article
Páginas:
-
PubMed:
39337366

Citas Recibidas en Web of Science: 1

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • autism spectrum disorders, human leukocyte antigen (HLA), immunogenetics, sex-based risk factors, sex-bias disease

Campos de Estudio

Proyectos asociados

PID10470. No se ingresará dinero en el CIPF. La ayuda consiste en un estudio genómico (long & read-sequencing) para 25 muestras.

Investigador Principal: CARMEN ESPINÓS ARMERO

EASI- Genomics . 2020

Nanoplataforma Polipeptídica Multimodal de Precisión para el Tratamiento y Monitorización de Tumores Metastásicos. Colab I-36, I-12, I-63, servicio citómica, uji y gva (Esther Roselló)

Investigador Principal: MARIA JESUS VICENT DOCON

CONSELLERIA DE EDUCACION . 2022

ESTUDIO DE LAS DIFERENCIAS DE SEXO EN ENFERMEDADES NEURODEGENERATIVAS CON ABORDAJES

Investigador Principal: FRANCISCO GARCÍA GARCÍA

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2022

TECNICO INFRAESTRUCTURAS

Investigador Principal: FRANCISCO GARCÍA GARCÍA

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2024

CIACIF Antonio Porlan

Investigador Principal: FRANCISCO GARCÍA GARCÍA

GENERALITAT VALENCIANA

Ayuda Movilidad FPU20/03544

Investigador Principal: FRANCISCO GARCÍA GARCÍA

MINISTERIO EDUCACIÓN, CULT. Y DEPO. . 2024

Metabolic strategies to stimulate myelin repair and prevent

MINISTERIO DE SANIDAD Y POL. SOC. E IGUAL.- PNSD . 2024

Impacto de la diferencia de sexo en las enfermedades de Park

Investigador Principal: FRANCISCO GARCÍA GARCÍA

GENERALITAT VALENCIANA . 2024

EMBO Scientific Exchange Grant - Irene Soler

Investigador Principal: FRANCISCO GARCÍA GARCÍA

EMBO . 2024

Compartir